|Bid||136.50 x 200|
|Ask||136.51 x 300|
|Day's Range||136.20 - 136.90|
|52 Week Range||109.32 - 137.00|
|PE Ratio (TTM)||22.95|
|Earnings Date||Jul 18, 2017|
|Dividend & Yield||3.36 (2.46%)|
|1y Target Est||131.83|
Income-seeking investors should look close to home for their best investing ideas.
Here's why Celgene stock is a keeper.
The FDA has approved its first commercial medicine, and because it could reshape a big indication, the company may have just gotten a lot more interesting to suitors.